Nikita pawar

💥There was no evidence that HIF prolyl hydroxylase inhibitors and ESA had different effects on MACE in people with dialysis-dependent CKD or people with nondialysis-dependent CKD. 💥There was no evidence that HIF PHI and placebo had different effects on MACE in people with nondialysis-dependent #CKD. 💥The lack of difference between HIF PHI and ESA or placebo was observed for individual components of MACE and cardiovascular death. 💥 In nondialysis-dependent CKD, #dialysis access thrombosis, venous thromboembolism, infections, and hyperkalemia occurred more frequently with HIF prolyl hydroxylase inhibitors in placebo-controlled trials but not in ESA-controlled trials. eviden.cc/3z2CLzM